Literature DB >> 2510489

The morphologic spectrum of dilated cardiomyopathy and its relation to immune-response genes.

E Arbustini1, A Gavazzi, R Pozzi, M Grasso, A Pucci, C Campana, G Graziano, M Martinetti, M Cuccia, L Salvaneschi.   

Abstract

Endomyocardial biopsies from 174 patients with dilated cardiomyopathy (DC) were examined. Eight patients with histologically proven myocarditis were excluded from the study. A peculiar pattern of oversized and bizarre nuclei was observed in only some of the remaining patients. Two groups were identified: those with and without this feature (groups A and B, respectively). Myocyte width, nuclear diameter and nuclear/sarcoplasmic ratio were significantly higher in group A. The mean respective values were 36 +/- 5 mu, 14 +/- 3 mu and 0.41 +/- 0.08 for group A versus 20 +/- 8 mu, 7 +/- 2 mu and 0.37 +/- 0.08 for group B. Interstitial fibrosis was similarly present in groups A and B. Endocardial thickness was significantly increased in all patients, with group A showing the highest mean value. The morphologic features showed no correlation with the clinical condition of the patients at time of presentation. HLA typing was performed in 50 consecutive patients, 38 from group A and 12 from group B. DR4 and DR5 antigens were significantly more frequent in DC patients than in a normal population control (400 blood donors), while DR3 was less frequent. Group A was more strongly associated with the DR5 antigen than group B (55.3 vs 25.0%, respectively). It was less strongly associated with the DR4 antigen compared with group B (21.5 vs 41.7%, respectively). No difference was observed between the 2 groups concerning negative association with the DR3 antigen. Endomyocardial biopsies from DC patients reveal marked morphologic changes from patient to patient.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2510489     DOI: 10.1016/0002-9149(89)90796-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  11 in total

1.  Idiopathic dilated cardiomyopathy: familial prevalence and HLA distribution.

Authors:  C J McKenna; M B Codd; H A McCann; D D Sugrue
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

2.  Myofibrillar protein structure and assembly during idiopathic dilated cardiomyopathy.

Authors:  R J Levine; J B Caulfield; P Norton; P D Chantler; M R Deziel; H S Slayter; S S Margossian
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

3.  Absence of linkage between idiopathic dilated cardiomyopathy and candidate genes involved in the immune function in a large Italian pedigree.

Authors:  M Krajinovic; L Mestroni; G M Severini; B Pinamonti; F Camerini; A Falaschi; M Giacca
Journal:  J Med Genet       Date:  1994-10       Impact factor: 6.318

4.  A meta-analysis of HLA-DR polymorphism and genetic susceptibility to idiopathic dilated cardiomyopathy.

Authors:  Bo Jin; Xin-Ping Luo; Huan-Chun Ni; Wei Shen; Hai-Ming Shi; Yong Li
Journal:  Mol Biol Rep       Date:  2011-05-10       Impact factor: 2.316

5.  Matrix remodelling in dilated cardiomyopathy entails the occurrence of oncofetal fibronectin molecular variants.

Authors:  U Gabler; A Berndt; H Kosmehl; U Mandel; L Zardi; S Müller; A Stelzner; D Katenkamp
Journal:  Heart       Date:  1996-04       Impact factor: 5.994

6.  Genetic and ultrastructural studies in dilated cardiomyopathy patients: a large deletion in the lamin A/C gene is associated with cardiomyocyte nuclear envelope disruption.

Authors:  Pallavi Gupta; Zofia T Bilinska; Nicolas Sylvius; Emilie Boudreau; John P Veinot; Sarah Labib; Pierrette M Bolongo; Akil Hamza; Tracy Jackson; Rafal Ploski; Michal Walski; Jacek Grzybowski; Ewa Walczak; Grzegorz Religa; Anna Fidzianska; Frédérique Tesson
Journal:  Basic Res Cardiol       Date:  2010-02-03       Impact factor: 17.165

7.  Do specific HLA antigens predispose to ischaemic heart disease or idiopathic dilated cardiomyopathy?

Authors:  S C Grant; S Sheldon; P A Dyer; R D Levy; N H Brooks
Journal:  Br Heart J       Date:  1994-01

8.  HLA-DRB1 gene polymorphism in patients with dilated cardiomyopathy.

Authors:  Q Wang; Y Liao; F Gong; H Mao; J Zhang
Journal:  J Tongji Med Univ       Date:  2000

9.  Possible association of HLA-DRB1 gene with the autoantibody against myocardial mitochondria ADP/ATP carrier in dilated cardiomyopathy.

Authors:  Qiufen Wang; Yuhua Liao; Feili Gong; Huanyuan Mao; Jinzhi Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2002

10.  Cellular hypertrophy in cardiomyopathic patients is associated with lower creatine-stimulated mitochondrial respiration.

Authors:  M Popovich; S Kostin; T Branishte; V Kobets; V Kapelko
Journal:  Mol Cell Biochem       Date:  1995-02-09       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.